Who cares what the naysayers say. Fer godsakes, th

Who cares what the naysayers say. Fer godsakes, the past doesnt guarantee future success in biotechs. Clinical trials do. And so does money. A lot of it as ct are expensive. Is lympro going to be the first revenue catalyst? So far we have no clue but hopefully gerald will finally throw us shareholders a bone before the end of the year.

My Agenda: To see Amarantus prosper so I can make a nice return on my investment.